Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1995-2-27
|
pubmed:abstractText |
Endogenous adenosine in the extracellular space inhibits neuronal activity. The roles of adenosine kinase, S-adenosylhomocysteine-hydrolase and adenosine deaminase activities in the regulation of the adenosine levels were investigated in rat hippocampal slices. Iodotubercidin, an inhibitor of adenosine kinase, added to the perfusion fluid at 5 microM increased the release of adenosine from the slices more than 2-fold. Iodotubercidin treatment caused inhibition of population spike discharges and hyperpolarization of pyramidal cells, mimicking the effects of exogenously applied adenosine. Adenosine dialdehyde, an inhibitor of S-adenosylhomocysteine hydrolase, and erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA), an inhibitor of adenosine deaminase had little or no effect on the parameters tested. The action of iodotubercidin was greater during deaminase inhibition. The A1-receptor antagonist DPCPX had actions opposite to those of adenosine and blocked the electrophysiological effects of exogenous adenosine and of iodotubercidin. Thus adenosine kinase activity is a significant factor in the regulation of adenosine levels in the hippocampus.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1,3-dipropyl-8-cyclopentylxanthine,
http://linkedlifedata.com/resource/pubmed/chemical/5-iodotubercidin,
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine,
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/Inosine,
http://linkedlifedata.com/resource/pubmed/chemical/Purinergic P1 Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Tubercidin,
http://linkedlifedata.com/resource/pubmed/chemical/Xanthines,
http://linkedlifedata.com/resource/pubmed/chemical/periodate-oxidized adenosine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0028-3908
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1049-53
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:7838317-Adenosine,
pubmed-meshheading:7838317-Adenosine Kinase,
pubmed-meshheading:7838317-Animals,
pubmed-meshheading:7838317-Hippocampus,
pubmed-meshheading:7838317-Inosine,
pubmed-meshheading:7838317-Kinetics,
pubmed-meshheading:7838317-Membrane Potentials,
pubmed-meshheading:7838317-Neurons,
pubmed-meshheading:7838317-Purinergic P1 Receptor Antagonists,
pubmed-meshheading:7838317-Rats,
pubmed-meshheading:7838317-Rats, Wistar,
pubmed-meshheading:7838317-Tubercidin,
pubmed-meshheading:7838317-Xanthines
|
pubmed:year |
1994
|
pubmed:articleTitle |
Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices.
|
pubmed:affiliation |
Physiologische Institute I, Heinrich-Heine-Universität Düsseldorf, Germany.
|
pubmed:publicationType |
Journal Article,
In Vitro
|